X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-02 | XLO | Gilead Sciences, Inc. | 10% | P - Purchase | $0.76 | +485,250 | 7,345,473 | +7% | +$368,790 | |||||
2024-02-08 | XLO | Atlas Venture Fund Xi, L.P. | 10% | S - Sale | $0.64 | -1,000 | 2,754,109 | 0% | -$640 | ||||||
| M | 2024-01-11 | XLO | Atlas Venture Fund Xi, L.P. | 10% | S - Sale | $0.85 | -4,235 | 2,755,109 | 0% | -$3,600 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |